Fol­low­ing a tu­mul­tuous year, Emer­gen­t's founder will re­tire in April

Af­ter what was al­most cer­tain­ly the most tur­bu­lent year in his com­pa­ny’s his­to­ry, Fuad El-Hi­b­ri, the founder and orig­i­nal CEO of Emer­gent BioSo­lu­tions, will re­tire in April.

The move comes 24 years af­ter Emer­gent was found­ed as Bio­Port with just one prod­uct, its an­thrax vac­cine Bio­Thrax. El-Hi­b­ri was the CEO for 14 years and took the com­pa­ny pub­lic in 2006. Af­ter he stepped down as the CEO, he re­mained on board as chair­man for the next 10 years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER